organophosphonates has been researched along with Colonic Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, QY; Hong, P; Hu, HF; Huang, XH; Li, B; Xu, WW; Yan, X; Yang, J; Ye, F; Zhang, QH | 1 |
| Prestwich, GD; Xu, X; Yang, G; Zhang, H | 1 |
| Charbonnière, LJ; Christine, C; Clavier, S; Ehret-Sabatier, L; Koubemba, M; Orend, G; Saupe, F; Shakir, S | 1 |
| Baek, NI; Kang, HM; Kim, JH; Kwon, BM; Lee, MY; Son, KH; Yang, DC | 1 |
| Chang, HJ; Hong, SH; Jeon, E; Park, JG; Shin, YK; Yoo, BC | 1 |
| Alberts, DS; Dorr, RT; Remers, WA; Sami, SM; Sólyom, AM | 1 |
| Boggi, U; Caputo, S; Danesi, R; Del Tacca, M; Di Paolo, A; Lastella, M; Macchia, M; Marchetti, A; Mosca, F | 1 |
| Berger, MR; Galeano, A; Keppler, BK | 1 |
1 review(s) available for organophosphonates and Colonic Neoplasms
| Article | Year |
|---|---|
Evaluating dual activity LPA receptor pan-antagonist/autotaxin inhibitors as anti-cancer agents in vivo using engineered human tumors.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Enzyme Inhibitors; Extracellular Matrix; Female; Humans; Hydrogels; Liver Neoplasms; Lysophospholipids; Male; Mice; Mice, Nude; Multienzyme Complexes; Organophosphonates; Palmitates; Phosphodiesterase I; Phosphoric Diester Hydrolases; Pyrophosphatases; Receptors, Lysophosphatidic Acid; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2009 |
7 other study(ies) available for organophosphonates and Colonic Neoplasms
| Article | Year |
|---|---|
Adefovir dipivoxil sensitizes colon cancer cells to vemurafenib by disrupting the KCTD12-CDK1 interaction.
Topics: Adenine; Antineoplastic Agents; CDC2 Protein Kinase; Cell Line, Tumor; Colonic Neoplasms; Humans; Organophosphonates; Protein Binding; Proteins; Reverse Transcriptase Inhibitors; Vemurafenib | 2019 |
Synthesis of an activated phosphonated bifunctional chelate with potential for PET imaging and radiotherapy.
Topics: Antibodies, Monoclonal; Biopsy; Chelating Agents; Colonic Neoplasms; Cysteine; Ethylamines; Fluorescent Antibody Technique; Humans; Hydrogen-Ion Concentration; Hydrolysis; Lysine; Multimodal Imaging; Neoplasm Proteins; Organophosphonates; Peptides; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Spectrometry, Fluorescence; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staining and Labeling; Tenascin; Tomography, X-Ray Computed | 2012 |
Relationship between flavonoid structure and inhibition of farnesyl protein transferase.
Topics: Alkyl and Aryl Transferases; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Colonic Neoplasms; Flavonoids; Humans; Inhibitory Concentration 50; Organophosphonates; Phytotherapy; Plant Extracts; Plants, Medicinal | 2004 |
Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line.
Topics: Amino Acids; Aminobutyrates; Antimetabolites, Antineoplastic; Antineoplastic Agents; Blotting, Western; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Colonic Neoplasms; Cyclic AMP; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Electrophoresis, Gel, Two-Dimensional; Excitatory Amino Acid Agonists; Fluorouracil; Humans; Ligands; Organophosphonates; Receptors, Metabotropic Glutamate; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tetrazolium Salts; Thiazoles; Time Factors | 2004 |
Amino-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H- dibenz[de,h]isoquinoline-1,3-diones. Synthesis, antitumor activity, and quantitative structure--activity relationship.
Topics: Adenine; Animals; Antineoplastic Agents; Cattle; Colonic Neoplasms; DNA; Doxorubicin; Heart Diseases; Humans; Imides; Isoquinolines; Leukemia P388; Male; Mice; Mice, Inbred DBA; Mitoxantrone; Naphthalimides; Organophosphonates; Structure-Activity Relationship; Tumor Cells, Cultured | 1995 |
Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells.
Topics: Alkyl and Aryl Transferases; Animals; Cell Division; Cell Transformation, Neoplastic; Colonic Neoplasms; Enzyme Inhibitors; Female; Humans; Mice; Organophosphonates; Polyenes; Polyunsaturated Alkamides; Protein Prenylation; Transplantation, Heterologous; Tumor Cells, Cultured | 2001 |
Activity of two platinum-linked phosphonic acids against autochthonous rat colorectal cancer as well as in two human colon-cancer cell lines.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Humans; Male; Organophosphonates; Organophosphorus Compounds; Organoplatinum Compounds; Rats; Rats, Inbred Lew; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1992 |